Updated: 3/2/2020

Impotence / Erectile Dysfunction

0%
Topic
Review Topic
0
0
0%
0%
Questions
1 1
0
0
Snapshot
  • A 60-year-old man presents to his primary care physician for evaluation of erectile dysfunction. His wife died 5 years ago and he would like to start dating again. He denies having any life stressors. He reports having no morning or night-time erections. His past medical history includes hyperlipidemia managed with medication and pre-diabetes managed with an active lifestyle and diet. His physician sends him for further laboratory workup and counsels him on the use of sildenafil.
Introduction
  • Clinical definition
    • impotence or erectile dysfunction is the inability to have or maintain an erection for intercourse
  • Epidemiology
    • incidence increases with age
    • demographics
      • > 40-year-old men
    • risk factors
      • hypertension
      • diabetes
      • chronic prostatitis
      • smoking
      • obesity
  • Etiology
    • primary erectile dysfunction with normal functioning penis
      • psychogenic
        • fear of intimacy, depression, stress, anxiety, or guilt
        • performance anxiety
        • common post-myocardial infarction secondary to anxiety 
      • ↓ testosterone
      • ↓ libido
      • ↓ desire
      • thyroid disease
      • Cushing’s syndrome
    • secondary erectile dysfunction with an abnormally functioning penis
      • vascular disease
        • atherosclerosis causing ↓ blood flow to the organ
      • diabetes
      • drugs
      • alcohol
      • antidepressants
      • neurologic
        • stroke
        • seizures
        • multiple sclerosis
      • endocrine
        • hypogonadism
        • hyperprolactinemia
      • trauma
  • Pathogenesis
    • normal physiology
      • nitric oxide is released and leads to formation of 3’,5’-cyclo-guanosine monophosphate (3,’5’-cGMP)
        • 3’,5’-cGMP causes compression of veins which impedes venous return and causes an erection
    • erectile dysfunction
      • various etiologies likely interfere with the pathway, causing low concentrations of 3’,5’-cGMP
  • Associated conditions
    • depression
    • benign prostatic hypertrophy
  • Prognosis
    • natural history of disease
      • most can be managed but not cured
Presentation
  • Symptoms
    • presence or absence of morning or nighttime erections
      • if present, this may suggest psychogenic etiology
    • difficulty with arousal
    • difficulty with orgasms
  • Physical exam
    • may have hypogonadism
Studies
  • Labs
    • fasting blood sugar
    • hemoglobin A1c
    • lipid profile
    • morning testosterone level
      • if consistently low on 2 or more tests obtain
        • luteinizing hormone (LH)
        • follicle-stimulating hormone (FSH)
    • thyroid function tests
  • Nocturnal penile tumescence and rigidity test
    • help differentiate between primary and secondary etiology
Differential
  • Premature ejaculation
Treatment
  • Conservative
    • weight loss and diet modifications
      • indications
        • obesity and diabetes are risk factors for erectile dysfunction
    • counseling
      • indications
        • for psychogenic erectile dysfunction
  • Medical
    • phosphodiesterase-5 (PDE-5) inhibitor
      • drugs
        • sildenafil
        • vardenafil
      • contraindications
        • use with nitrates 
          • increased risk of syncope and hypotension
  • Operative
    • implants or injection therapy
      • indications
        • if patients are contraindicated to PDE-5 inhibitors
Complications
  • Relationship problems

 

Please rate topic.

Average 5.0 of 1 Ratings

Thank you for rating! Please vote below and help us build the most advanced adaptive learning platform in medicine

The complexity of this topic is appropriate for?
How important is this topic for board examinations?
How important is this topic for clinical practice?
Questions (1)
Lab Values
Blood, Plasma, Serum Reference Range
ALT 8-20 U/L
Amylase, serum 25-125 U/L
AST 8-20 U/L
Bilirubin, serum (adult) Total // Direct 0.1-1.0 mg/dL // 0.0-0.3 mg/dL
Calcium, serum (Ca2+) 8.4-10.2 mg/dL
Cholesterol, serum Rec: < 200 mg/dL
Cortisol, serum 0800 h: 5-23 μg/dL //1600 h:
3-15 μg/dL
2000 h: ≤ 50% of 0800 h
Creatine kinase, serum Male: 25-90 U/L
Female: 10-70 U/L
Creatinine, serum 0.6-1.2 mg/dL
Electrolytes, serum  
Sodium (Na+) 136-145 mEq/L
Chloride (Cl-) 95-105 mEq/L
Potassium (K+) 3.5-5.0 mEq/L
Bicarbonate (HCO3-) 22-28 mEq/L
Magnesium (Mg2+) 1.5-2.0 mEq/L
Estriol, total, serum (in pregnancy)  
24-28 wks // 32-36 wks 30-170 ng/mL // 60-280 ng/mL
28-32 wk // 36-40 wks 40-220 ng/mL // 80-350 ng/mL
Ferritin, serum Male: 15-200 ng/mL
Female: 12-150 ng/mL
Follicle-stimulating hormone, serum/plasma Male: 4-25 mIU/mL
Female: premenopause: 4-30 mIU/mL
midcycle peak: 10-90 mIU/mL
postmenopause: 40-250
pH 7.35-7.45
PCO2 33-45 mmHg
PO2 75-105 mmHg
Glucose, serum Fasting: 70-110 mg/dL
2-h postprandial:<120 mg/dL
Growth hormone - arginine stimulation Fasting: <5 ng/mL
Provocative stimuli: > 7ng/mL
Immunoglobulins, serum  
IgA 76-390 mg/dL
IgE 0-380 IU/mL
IgG 650-1500 mg/dL
IgM 40-345 mg/dL
Iron 50-170 μg/dL
Lactate dehydrogenase, serum 45-90 U/L
Luteinizing hormone, serum/plasma Male: 6-23 mIU/mL
Female: follicular phase: 5-30 mIU/mL
midcycle: 75-150 mIU/mL
postmenopause 30-200 mIU/mL
Osmolality, serum 275-295 mOsmol/kd H2O
Parathyroid hormone, serume, N-terminal 230-630 pg/mL
Phosphatase (alkaline), serum (p-NPP at 30° C) 20-70 U/L
Phosphorus (inorganic), serum 3.0-4.5 mg/dL
Prolactin, serum (hPRL) < 20 ng/mL
Proteins, serum  
Total (recumbent) 6.0-7.8 g/dL
Albumin 3.5-5.5 g/dL
Globulin 2.3-3.5 g/dL
Thyroid-stimulating hormone, serum or plasma .5-5.0 μU/mL
Thyroidal iodine (123I) uptake 8%-30% of administered dose/24h
Thyroxine (T4), serum 5-12 μg/dL
Triglycerides, serum 35-160 mg/dL
Triiodothyronine (T3), serum (RIA) 115-190 ng/dL
Triiodothyronine (T3) resin uptake 25%-35%
Urea nitrogen, serum 7-18 mg/dL
Uric acid, serum 3.0-8.2 mg/dL
Hematologic Reference Range
Bleeding time 2-7 minutes
Erythrocyte count Male: 4.3-5.9 million/mm3
Female: 3.5-5.5 million mm3
Erythrocyte sedimentation rate (Westergren) Male: 0-15 mm/h
Female: 0-20 mm/h
Hematocrit Male: 41%-53%
Female: 36%-46%
Hemoglobin A1c ≤ 6 %
Hemoglobin, blood Male: 13.5-17.5 g/dL
Female: 12.0-16.0 g/dL
Hemoglobin, plasma 1-4 mg/dL
Leukocyte count and differential  
Leukocyte count 4,500-11,000/mm3
Segmented neutrophils 54%-62%
Bands 3%-5%
Eosinophils 1%-3%
Basophils 0%-0.75%
Lymphocytes 25%-33%
Monocytes 3%-7%
Mean corpuscular hemoglobin 25.4-34.6 pg/cell
Mean corpuscular hemoglobin concentration 31%-36% Hb/cell
Mean corpuscular volume 80-100 μm3
Partial thromboplastin time (activated) 25-40 seconds
Platelet count 150,000-400,000/mm3
Prothrombin time 11-15 seconds
Reticulocyte count 0.5%-1.5% of red cells
Thrombin time < 2 seconds deviation from control
Volume  
Plasma Male: 25-43 mL/kg
Female: 28-45 mL/kg
Red cell Male: 20-36 mL/kg
Female: 19-31 mL/kg
Cerebrospinal Fluid Reference Range
Cell count 0-5/mm3
Chloride 118-132 mEq/L
Gamma globulin 3%-12% total proteins
Glucose 40-70 mg/dL
Pressure 70-180 mm H2O
Proteins, total < 40 mg/dL
Sweat Reference Range
Chloride 0-35 mmol/L
Urine  
Calcium 100-300 mg/24 h
Chloride Varies with intake
Creatinine clearance Male: 97-137 mL/min
Female: 88-128 mL/min
Estriol, total (in pregnancy)  
30 wks 6-18 mg/24 h
35 wks 9-28 mg/24 h
40 wks 13-42 mg/24 h
17-Hydroxycorticosteroids Male: 3.0-10.0 mg/24 h
Female: 2.0-8.0 mg/24 h
17-Ketosteroids, total Male: 8-20 mg/24 h
Female: 6-15 mg/24 h
Osmolality 50-1400 mOsmol/kg H2O
Oxalate 8-40 μg/mL
Potassium Varies with diet
Proteins, total < 150 mg/24 h
Sodium Varies with diet
Uric acid Varies with diet
Body Mass Index (BMI) Adult: 19-25 kg/m2
Calculator

Question locked
Sorry, this question is for
PEAK Premium Subscribers only
Upgrade to PEAK
Evidences (2)
Topic COMMENTS (0)
Private Note